ArticleFrontiers in immunology2026
Virtual screening identifies specnuezhenide as a potential therapeutic agent for rosacea via KLK5/TLR4/NF-κB pathway inhibition and metabolic modulation.
Jingang Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.